These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 30831080)
21. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis. Gu H; Lin R; Zheng F; Zhang Q J Mol Histol; 2021 Feb; 52(1):31-44. PubMed ID: 33099720 [TBL] [Abstract][Full Text] [Related]
22. FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer. Yang L; Cui J; Wang Y; Tan J Biomed Pharmacother; 2019 Oct; 118():109342. PubMed ID: 31545230 [TBL] [Abstract][Full Text] [Related]
23. LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer. Zhang Z; Ye B; Lin Y; Liu W; Deng J; Ji W Clin Transl Oncol; 2023 Nov; 25(11):3217-3229. PubMed ID: 37184781 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of the long non-coding RNA FAM83H-AS1 in gastric cancer and its clinical significance. Da J; Liu P; Wang R; Bu L Pathol Res Pract; 2019 Oct; 215(10):152616. PubMed ID: 31493939 [TBL] [Abstract][Full Text] [Related]
25. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y; Dun Y; Zhou S; Huang XH Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer. Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685 [TBL] [Abstract][Full Text] [Related]
27. Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis. Zhang Y; Yu Y; Cao X; Chen P Bioengineered; 2022 Mar; 13(3):6476-6489. PubMed ID: 35260044 [TBL] [Abstract][Full Text] [Related]
28. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells. Li H; Zhou Y; Cheng H; Tian J; Yang S Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621 [TBL] [Abstract][Full Text] [Related]
29. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. Luo N; Zhang K; Li X; Hu Y J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280 [TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [TBL] [Abstract][Full Text] [Related]
31. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894 [No Abstract] [Full Text] [Related]
32. Regulations of Exosomal-Transmitted Zhou F; Xu X; Wei W; Chen X; Sun L Discov Med; 2023 Oct; 35(178):877-886. PubMed ID: 37811626 [TBL] [Abstract][Full Text] [Related]
33. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway. Zhao X; Cheng Z; Wang J Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194 [TBL] [Abstract][Full Text] [Related]
34. HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer. Chai Y; Liu J; Zhang Z; Liu L Cancer Med; 2016 Jul; 5(7):1588-98. PubMed ID: 27075229 [TBL] [Abstract][Full Text] [Related]
35. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer. Ma D; Chen C; Wu J; Wang H; Wu D Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352 [TBL] [Abstract][Full Text] [Related]
36. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer. Lv Y; Li H; Li F; Liu P; Zhao X Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer. Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831 [TBL] [Abstract][Full Text] [Related]
38. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer. El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293 [TBL] [Abstract][Full Text] [Related]
39. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010 [TBL] [Abstract][Full Text] [Related]
40. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4. Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]